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Jiyoung Kim1, Meshail Okla1, Anjeza Erickson, Timothy Carr, Sathish Kumar Natarajan, and X Soonkyu Chung2
From the Department of Nutrition and Health Sciences, the University of Nebraska, Lincoln, Nebraska 68583
Emerging evidence suggests that n-3 polyunsaturated fatty
acids (PUFA) promote brown adipose tissue thermogenesis.
However, the underlying mechanisms remain elusive. Here, we
hypothesize that n-3 PUFA promotes brown adipogenesis by
modulating miRNAs. To test this hypothesis, murine brown
preadipocytes were induced to differentiate the fatty acids of
palmitic, oleate, or eicosapentaenoic acid (EPA). The increases
of brown-specific signature genes and oxygen consumption rate
by EPA were concurrent with up-regulation of miR-30b and 378
but not by oleate or palmitic acid. Next, we hypothesize that free
fatty acid receptor 4 (Ffar4), a functional receptor for n-3 PUFA,
modulates miR-30b and 378. Treatment of Ffar4 agonist
(GW9508) recapitulated the thermogenic activation of EPA by
increasing oxygen consumption rate, brown-specific marker
genes, and miR-30b and 378, which were abrogated in Ffar4silenced cells. Intriguingly, addition of the miR-30b mimic was
unable to restore EPA-induced Ucp1 expression in Ffar4-depleted cells, implicating that Ffar4 signaling activity is required
for up-regulating the brown adipogenic program. Moreover,
blockage of miR-30b or 378 by locked nucleic acid inhibitors
significantly attenuated Ffar4 as well as brown-specific signature gene expression, suggesting the signaling interplay between
Ffar4 and miR-30b/378. The association between miR-30b/378
and brown thermogenesis was also confirmed in fish oil-fed
C57/BL6 mice. Interestingly, the Ffar4 agonism-mediated signaling axis of Ffar4-miR-30b/378-Ucp1 was linked with an elevation of cAMP in brown adipocytes, similar to cold-exposed or
fish oil-fed brown fat. Taken together, our work identifies a
novel function of Ffar4 in modulating brown adipogenesis
partly through a mechanism involving cAMP activation and upregulation of miR-30b and miR-378.

There are two specific types of fat with opposite functions,
brown adipose tissue (BAT)3 and white adipose tissue (WAT).
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WAT stores energy in the form of triglyceride, whereas BAT
dissipates energy in the form of heat via uncoupling protein 1
(UCP1) (1). Recent advances in our understanding of BAT biology in humans have provided a new insight into weight loss
strategies by boosting BAT thermogenesis. Despite the surge of
research for identifying cellular and molecular regulators of
brown fat development (2, 3), the role of dietary constituents,
particularly dietary fatty acids (FA), in thermogenic activation
is poorly understood. Depending on the degree of desaturation
and the n-6/n-3 ratio, FA differentially control adiposity, insulin sensitivity, immune response (4), and probably energy
expenditure (5–7). Lately, it has been suggested that n-3 polyunsaturated FA (PUFA) stimulate beige/brown adipogenesis in
primary murine adipogenic precursor cells (5) as well as
C57BL/6 mice (6, 7). The latter animal study suggests that n-3
PUFA are associated with sympathetic activation and increased
␤3-adrenergic receptor (Adrb3) signaling (7). However, the
underlying mechanistic details of how dietary n-3 PUFA upregulate brown fat development and thermogenesis remain
unknown.
MicroRNAs (miRNAs) play critical functions in brown adipocyte differentiation and maintenance. Deletion of adiposespecific dicer promotes white-like phenotype of brown precursor cells (8). Similarly, disruption of miRNA biogenesis by
deleting fat-specific Dgcr8, a molecular anchor necessary for
the recognition of pri-miRNA, results in defective BAT formation and severe cold intolerance (9). Recently, miR-193b/365
cluster was identified to be enriched in BAT and demonstrated
as a key regulator to promote brown adipogenesis by targeting
Runx1t1, a transcription factor that drives myocyte formation
(10). In addition to suppression of myogenic lineage commitment, miR-196a promotes brown adipogenesis by inhibiting
white adipocyte commitment (11). The brown transcriptional
program could be corroborated by miR-378 that increases
cAMP production via targeted degradation of phosphodiesterase 1B (Pde1b) (12) or by miR-30b that promotes degradation
of Rip140, a transcriptional corepressor (13). Conversely,
decreased levels of miR-133, miR-27a, miR-106b/93, and miR155 have shown to enhance brown adipogenesis by preventing

gen consumption rate; LNA, locked nucleic acid; PPAR, peroxisome proliferator-activated receptor; FA, fatty acid; ANOVA, analysis of variance; FCCP,
carbonyl cyanide 4-trifluoromethoxyphenylhydrazone; qPCR, quantitative
PCR; FFAR, free fatty acid receptor; HF, high fat; LF, low fat; PO, palm oil; OO,
olive oil; FO, fish oil; BF3, boron trifluoride; [Ca2⫹]i, intracellular calcium;
iBAT, interscapular brown adipose tissue; miRNA, microRNA; DEXA, dexamethasone; RISC, RNA-induced silencing complex.
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FIGURE 1. Dietary EPA promotes brown adipogenesis and OCR in primary murine brown progenitor cells. Brown progenitor cells were isolated from iBAT,
and differentiation was induced for 7 days with either vehicle (Veh) (BSA) or 100 M palmitate (PA), OA, or EPA. A, brown signature gene expression profile of
Ucp1, Cidea, Glut4, Prdm16, Ppar␥, and Elovl3 by qPCR. B, Western blotting analysis of Ucp1, Ppar␥, aP2, Prdm16, and Rip140 and ␤-actin (loading control). C, OCR
in brown adipocytes treated with vehicle (green), OA (red), and EPA (blue) determined by Seahorse extracellular analyzer. Arrow indicates the addition of
respiratory inhibitors of oligomycin (Oligo), FCCP, and antimycin A plus rotenone (A⫹R). All data are presented as mean ⫾ S.E. A, values not sharing a common
letter differ significantly (p ⬍ 0.05) by one-way ANOVA (n ⫽ 5 per group). C, *, p ⬍ 0.05; **, p ⬍ 0.01 by one-way ANOVA with comparison to the vehicle control
(n ⫽ 6 –7 per treatment). n.s., not significant.

targeted degradation of transcription factors of Prdm16 (14),
Ppar␥ (15), Ppar␣ (16), and C/ebp␤ (17), respectively (see Fig.
1E). However, it has not been investigated whether n-3 PUFA
play a role in regulating the miRNA network for brown
adipogenesis.
Supplementation of n-3 PUFA exerts multiple health benefits via activation of free fatty acid receptor 4 (Ffar4), previously
known as G-protein-coupled receptor 120 (Gpr120) (18). Oh et
al. (19) have demonstrated that Ffar4 senses n-3 PUFA triggering a broad spectrum of anti-inflammatory effects in macrophages. Furthermore, Ffar4 agonist has been shown to induce
potent insulin-sensitizing and anti-diabetic effects against high
fat (HF)-mediated obesity (20, 21). In addition, Ffar4-deficient
mice develop hepatic steatosis and insulin resistance, implicating the crucial role of Ffar4 in maintaining energy balance. In
humans, inhibition of FFAR4 signaling activity due to the
genetic mutation of the FFAR4 gene (p.R2700H) was highly
correlated with obesity risk (22). Although it is known that n-3
PUFA or pharmacological FFAR agonist modulate inflammation and glucose sensitivity in white adipocytes, little is known
regarding the effects of FFAR activation in brown adipogenesis
and BAT thermogenesis.
The objective of this study was to determine the underlying
mechanism by which n-3 PUFA promote BAT thermogenesis.
In this study, we hypothesized that n-3 PUFA stimulate brown
adipogenesis by modulating the miRNA network, thereby promoting brown transcriptional activation. We also hypothesized
that FFAR signaling activity will orchestrate activation of BAT
thermogenesis by n-3 PUFA. To test these hypotheses, we
investigated the signaling interplay that EPA coordinates Ffar4
and miRNAs in primary mouse brown preadipocytes. By using
miRNA mimics and inhibitors, silencing of Ffar4, as well as
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complementary analyses of diet-fed animals, we report that
Ffar4 plays a key role in promoting brown adipogenesis by EPA
in part through miR-30b and 378.

Results
EPA Promotes Brown Adipogenesis by Altering miRNA
Network—To investigate the impact of different dietary FA on
brown adipogenesis, murine primary brown adipogenic precursor cells from iBAT were treated with either vehicle (BSA)
or 100 M PA, OA, or EPA during brown adipogenesis. There
was a significant increase of brown signature gene expression of
Ucp-1, Cidea, Prdm16, PPAR␥, Glut4, and Elovl3 in EPAtreated culture compared with PA, OA, or vehicle (BSA) (Fig.
1A). In parallel with the mRNA profile, the EPA treatment
increased Ucp1, Ppar␥, Prdm16, and aP2 protein expression
(Fig. 1B). To determine the impacts of EPA treatment on mitochondrial energetics, oxygen consumption rates (OCR) were
determined. EPA treatment significantly increased the basal,
uncoupling, and maximal respiration compared with vehicle or
OA treatment (Fig. 1C).
Next, we examined whether EPA-induced up-regulation of
brown adipogenesis is associated with modification of miRNA
expression. Based on literature reviews, we selected 10 miRNAs
that alter the brown adipogenic program either by suppressing
or enhancing brown adipogenesis (Fig. 2A). To conform the
changes of miRNAs in BAT, miRNA levels in inguinal WAT
and iBAT were compared; the expression levels of miR-30b,
miR-193b, miR-365, miR-378, and miR-196a were significantly
higher in BAT than WAT, whereas those of miR-27a and miR133 were higher in WAT. There was no significant difference in
miR-106 and miR-133 expression between groups (Fig. 2B).
The brown differentiation with EPA, but not OA or PA, signifVOLUME 291 • NUMBER 39 • SEPTEBMER 23, 2016
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FIGURE 2. Dietary EPA modulates miRNA network for brown adipogenesis. A, schematic diagram depicting the miRNA network that regulates brown
adipogenesis. B, comparison of 10 representative miRNA expressions between subcutaneous WAT and interscapular BAT. *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍ 0.001
by Student’s t test. C, changes of miRNA expression of miR-30b, miR-193b, miR-365, miR-378, miR-196a, miR-27a, miR-93, miR-106b, miR-133, and miR-155. D,
mRNA expression of Rip140, Runxt1, and Pde1b by qPCR. All data are presented as mean ⫾ S.E. B, *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍ 0.001 by Student’s t test (from
n ⫽ 5 individual animal per depot). C and D, values not sharing a common letter differ significantly (p ⬍ 0.05) by one-way ANOVA (n ⫽ 4 per group). Veh, vehicle.

icantly increased miR-193/365 (3.4/2.9-fold), miR-378 (1.7fold), miR-196a (1.5-fold), miR-30b (2.3-fold), and miR-106/93
(1.3/1.6-fold) compared with vehicle (BSA). In contrast, EPA
did not significantly alter miRNA expression levels of miR-27a,
miR-93, miR-133, and miR-155 (Fig. 2C). It is also interesting
to note that OA had no significant impacts on the selected
miRNAs for brown adipogenesis, whereas PA decreased the
overall miRNA levels except for miR-193b/365 cluster and
miR-106 (Fig. 2C). Consistently, mRNA expressions of Rip140
and Runx1t1, the proposed target of miR-30b and miR-193b/
365 respectively, were significantly reduced compared with
vehicle control. It is also notable that EPA treatment is associated with decreased expression of RIP140 (Fig. 1B). Despite a
significant increase of miR-378, its proposed target of Pdeb1b
(12) did not differ from the vehicle control (Fig. 2D). In summary, EPA promotes brown adipogenesis and uncoupled respiration, which was associated with modulation of miRNAs.
FFAR4 Agonist Recapitulates Increase of Brown Adipogenesis
and miRNA Network for Brown Fat Development—It is well
established that FFAR4 (also known as GPR120) recognizes
long or medium chain of FA, including docosahexaenoic acid
SEPTEBMER 23, 2016 • VOLUME 291 • NUMBER 39

and EPA, and exerts a plethora of health benefits (23–25). Based
on these backgrounds, we asked whether FFAR4 signaling is
also involved in EPA-mediated brown adipogenesis and
miRNA modulation. To address this question, an increasing
dose (0, 1, 10, and 20 M) of GW9508, a FFAR4 agonist, was
added to the differentiating brown progenitor cells. Prdm16
expression, a master transcription factor for brown fat, was significantly increased even with 1 M GW9508 treatment. In
addition, Ucp1, Cidea, Elov3, and Glut4 mRNA levels were
increased in a dose-dependent manner, whereas Rip140 mRNA
expression was reduced stepwise with GW9508 (Fig. 3A). In
parallel with the changes of miRNA network by EPA (Fig. 2C),
expression levels of miR-30b, miR-365, miR-378, and miR-196a
were significantly elevated in GW9508-treated brown adipocytes (Fig. 3B). Similar to EPA treatment, GW9508 treatment
increased Ucp1, Ppar␥, aP2, and Prdm16 protein expression,
whereas decreased RIP140 protein levels compared with vehicle control (Fig. 3C). Next, brown adipocytes grown with or
without GW9508 were used to determine OCR. FFAR4 agonist
GW9508 significantly increased basal, uncoupling, and maximal respiration rate similar to EPA treatment (Fig. 3D). CollecJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Ffar4 agonist recapitulates EPA-mediated brown thermogenesis. Brown progenitor cells were isolated from iBAT and induced differentiation for
7 days with an increasing dose (0, 1, 10, and 20 M) of GW9508, a FFAR4 agonist. A, brown signature gene expression profile of Ucp1, Prdm16, Cidea, Elovl3, Glut4,
and Rip140 by qPCR. B, changes of miRNA expression of miR-30b, miR-193b, miR-365, miR-378, miR-196a, miR-27a, miR-93, miR-106b, miR-133, and miR-155.
C, representative Western blotting analysis of Ucp1, Ppar␥, aP2, and ␤-actin. D, OCR in brown adipocytes grown with vehicle (Veh) (green) or 20 M GW9508
(blue) determined by Seahorse extracellular analyzer. Arrow indicates the addition of respiratory inhibitors of oligomycin (Oligo), FCCP, and antimycin A plus
rotenone (A ⫹ R). All data are presented as mean ⫾ S.E. A, values not sharing a common letter differ significantly (p ⬍ 0.05) by one-way ANOVA (n ⫽ 5 per group).
B (n ⫽ 5); D (n ⫽ 6), *, p ⬍ 0.05; **, p ⬍ 0.01; ****, p ⬍ 0.0001 by Student’s t test.

tively, these data suggest that FFAR4 signaling participates in
up-regulation of brown thermogenic program probably by
modulating miRNAs.
miR-30b Regulates Brown Adipogenesis in FFAR4-dependent
Mechanism—It has been recently identified that miR-30b participates in brown thermogenesis by targeting Rip140, a nuclear
receptor corepressor (13). Among the 10 miRNAs that are relevant to brown adipogenesis, miR-30b seems to be a viable candidate responsible for EPA and FFAR4 agonist’s effect. To test
this notion, brown preadipocytes were transfected with either
miR-30b mimics or non-targeting control and then the cells
were differentiated to brown adipocytes in the presence or
absence of EPA incubation. The transfection of miR-30b mimics increased intracellular miR-30b levels ⬃20-fold. miR-30b
expression level was significantly higher in cultures that
received EPA ⫹ miR-30b mimics than those with miR-30b
alone, confirming that endogenous miR-30b was produced in
response to EPA treatment (Fig. 4A, left). Consistent with the
literature (13), exogenous miR-30b increased Ucp1 gene
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expression. Intriguingly, EPA treatment with miR-30b exhibited an additive increase in Ucp1 mRNA expression (Fig. 4A,
middle). Unexpectedly, Ffar4 expression was increased by
exogenous miR-30b, which was further increased by EPA addition (Fig. 4A, right) suggesting a synergistic effect of exogenous
and endogenous miR-30b for UCP1 up-regulation. It also
suggest that miR-30b may regulate Ffar4 as well as Ucp1
expression.
Subsequently, we attempted to determine the impact of
FFAR4 signaling activity on miR-30b function to augment
brown adipogenesis. For this purpose, we depleted FFAR4 by
transfecting siRNA. siRNA transfection effectively decreased
FFAR4 mRNA levels (⬃98%) quantified by qPCR analysis,
which was not reversed by EPA incubation (Fig. 4B). The silencing of Ffar4 completely dampened the EPA-mediated elevation
of Ucp1 and Cidea mRNA expression as well as miR-30b and
miR-378 expression (Fig. 4C), suggesting that Ffar4 signaling
might be required for miRNA modulation. To further determine whether miR-30b plays an independent role, exogenous
VOLUME 291 • NUMBER 39 • SEPTEBMER 23, 2016
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FIGURE 4. Ffar4 expression is required for EPA-mediated brown gene expression. A, miR-30b, Ucp1, and Ffar4 expression in EPA-treated brown adipocytes
with or without exogenous miR-30b mimics. B, transfection efficiency of siFFAR4. C, Ffar4-depleted brown preadipocytes were differentiated with or without
EPA and measured mRNA levels of Ucp1, Cidea, miR-30b, and miR-378 expression by qPCR. D, FFAR4-depleted brown preadipocytes were differentiated with
or without EPA along with exogenous miR-30b mimic. All data are presented as mean ⫾ S.E., n ⫽ 6/group. Values not sharing a common letter differ
significantly (p ⬍ 0.05) by one-way ANOVA.

miR-30b mimics were added to the FFAR4-silenced preadipocytes. Despite effective transfection of miR-30b mimics,
miR-30b failed to trigger up-regulation of Ucp1 and Cidea in
the absence of FFAR4 (Fig. 4D). Collectively, these results suggest the following: 1) Ffar4 and miR-30b have mutual interaction, and 2) Ffar4 signaling is required for miR-30b production
as well as its function to up-regulate brown-specific marker
gene expression.
Inhibition of miR-30b Attenuates Brown Adipogenesis—To
further determine the degree in which miR-30b contributes to
the Ffar4-mediated brown adipogenesis, miR-30b was sequestered by transfecting with antisense-LNA (locked nucleic acid)
miR-30b inhibitor. Transfection of LNA miR-30b inhibitor
completely blunted miR-30b production regardless of GW9508
incubation (Fig. 5A). Accordingly, the decrease of Rip140 gene
expression by GW9508 was reversed by LNA miR-30b inhibitor
(Fig. 5B). Consistent with miR-30b up-regulation of Ffar4 (Fig.
4A), sequestration of miR-30b by LNA miR30b inhibitor
resulted in a significant decrease of Ffar4 gene expression in
both basal and GW9508-treated cultures (Fig. 5C). It is important to note that inhibition of miR-30b attenuated GW9508induced Ucp1 expression by ⬃50% (Fig. 5D) and completely
abolished the increase of Cidea mRNA expression by GW9508
(Fig. 5E). Similarly, miR-378 was sequestered by antisense-LNA
SEPTEBMER 23, 2016 • VOLUME 291 • NUMBER 39

miR-378 inhibitor. The transfection with LNA miR-378 inhibitor effectively blocked the miR-378 expression (Fig. 5F). LNA
miR-378 transfection resulted in an increase of Pde1b in the
presence of GW9508 (Fig. 5G, 2nd and 4th lanes) and abolished
GW9508-mediated elevation of Ffar4 (Fig. 5H), Ucp1 (Fig. 5I),
and Cidea (Fig. 5J). These results suggest that miR-378 and
miR-30b may play a complementary role in up-regulating
brown adipogenesis. It is noteworthy that the inhibition of miR30b production by antisense-LNA miR-30b significantly dampened the GW9508-mediated elevation of OCR similar to the
vehicle control (Fig. 5K). In summary, these data suggest the
following: 1) miR-30b and miR-378 are not only downstream
targets of Ffar4 signaling, but they also reversely affect Ffar4
expression, and 2) blockage of miR-30b or miR-378 significantly attenuates Ffar4-induced up-regulation of the brown
adipogenic program.
Fish Oil Supplementation Increases Brown Thermogenesis
and Modifies miRNA Expression in Brown Fat—To confirm our
results in vivo, C57BL/6 mice were fed with either a LF diet (10%
of total calorie from fat) or an iso-caloric HF diet (50% of total
calorie from fat) enriched with palm oil (HF ⫹ PO), olive oil
(HF ⫹ OO), or fish oil (HF ⫹ FO) for 12 weeks. There was no
significant difference in food intake among the HF-fed diet
groups (Fig. 6A). The n-6/n-3 FA ratio was significantly higher
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 5. Inhibition of miR-30b or miR-378 attenuates Ffar4 agonist-mediated brown-specific gene activation. Brown preadipocytes were transfected
with LNA miR-30b inhibitor (LNA miR-30b) (A–E) or LNA miR-378 (LAN miR-378) (F–J) before stimulation of brown adipogenesis with or without GW9508. A,
miR-30b after transfection with LNA miR-30b. B–E, mRNA expression of Rip140 (B), Ffar4 (C), UCP1 (D), and Cidea (E). F, miR-378 after transfection with LNA
miR-378. G–J, mRNA expression of Pdeb1(G), Ffar4 (H), UCP1 (I), and Cidea (J). K, OCR by extracellular analyzer in brown adipocytes pretreated with either
non-targeting LNA (square) in combination with vehicle (Veh) (green) or GW9508 (blue), or LNA miR-30b (circle) in combination of vehicle (red) or GW9508
(violet). Arrow indicates the addition of respiratory inhibitors of oligomycin (Oligo), FCCP, and antimycin A plus rotenone (A ⫹ R). All data are presented as
mean ⫾ S.E., n ⫽ 6/group. Values not sharing a common letter differ significantly (p ⬍ 0.05) by one-way ANOVA. *, p ⬍ 0.05; ns, not significant by Student’s t
test .

in HF ⫹ OO- and HF ⫹ PA-fed mice but lower in HF ⫹ FO-fed
mice than the LF control, implying that n-3 PUFA are accumulated in adipose tissue (Fig. 6B). In accordance with other studies of n-3 PUFA supplementation (26), the FO-fed mice were
resistant to HF-mediated increase of fat mass and decrease of
lean mass by DEXA measurement (Fig. 6C). The HF ⫹ FO-fed
mice exhibited substantially lower fasting glucose levels than
HF ⫹ PO- or HF ⫹ OO-fed mice (Fig. 6D). Importantly, when
the mice were exposed to cold (8 °C) acutely (for 45 min), HF ⫹
FO-fed mice were able to maintain a core body temperature
higher than HF ⫹ PO or HF ⫹ OO. Furthermore, heat release
was significantly higher in HF ⫹ FO-fed than HF ⫹ PO- or HF ⫹
OO-fed mice (Fig. 6E). The increases of UCP1 protein and cytochrome c (Fig. 6F) and brown signature gene profiles of Ucp-1,
Cidea, Prdm16, PPAR␥, and PPAR␣ (Fig. 6G) were confirmed
in iBAT from HF ⫹ FO-fed mice compared with HF ⫹ PO- or
HF ⫹ OO-fed mice. These results are consistent with recent
publications showing thermogenic activation with FO supplementation (6, 7). Subsequently, we analyzed the five candidate
miRNAs that were up-regulated with EPA treatment in vitro; all
five miRNAs, miR-30b, miR-193b, miR-365, miR-196a, and
miR-378, were significantly up-regulated in iBAT from mice
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fed a HF ⫹ FO diet compared with HF ⫹ OO- or HF ⫹ PO
diet-fed mice (Fig. 6H).
Given that miR-30b and 378 are downstream targets of
cAMP (12, 13), we questioned whether cAMP signaling is associated with FFAR4 activation in brown adipocytes. The cold
exposure (5– 8 °C) for 2 weeks (samples from our previous studies (27)) significantly increased Ucp1 and Ffar4 expression
along with the increases of miR-30b and miR-378 in iBAT (Fig.
7A). Moreover, FO supplementation showed an additional
increase of Ffar4 as well as miR-30b and 378 expression (Fig.
7B). Next, we raised a question whether FFAR4 activation per se
triggers elevation of intracellular cAMP in brown adipocytes
linking the modulation of miR-30b and 378. There was a significant increase of cAMP levels in HF ⫹ FO-fed iBAT compared
with iBAT from mice fed a HF ⫹ OO. In fact, there was small
but a significant decrease of cAMP levels in HF ⫹ PO-fed mice
compared with HF ⫹ OO control (Fig. 7C). More surprisingly,
FFAR4 activation by GW9508 treatment significantly increased
cAMP levels in cultures of brown adipocytes without exogenous supply of catecholamine or Adrb3 activation (Fig. 7D).
These results suggest that FFAR4 agonism may promote autonomous brown differentiation program by elevating cAMP levVOLUME 291 • NUMBER 39 • SEPTEBMER 23, 2016
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FIGURE 6. Fish oil supplementation promotes brown thermogenesis. C57BL/6 mice were fed with LF or an iso-caloric HF diet containing 15% of palm oil
(HF ⫹ PO), olive oil (HF ⫹ OO), and fish oil (HF ⫹ FO) for 12 weeks (n ⫽ 8). A, food intake per day. B, n-6/n-3 ratio after 12 weeks of diet. C, lean and fat mass by
DEXA. D, fasting glucose levels. E, core body temperature measured by the rectal thermometer after acute cold exposure (8 °C) for 45 min (left) and representative thermography captured by IR camera (right). F, Western blotting analysis of Ucp1, cytochrome c (Cyt c), and ␤-actin. G, gene expression of Ucp1, Cidea,
Prdm16, Ppar␥, and Pgc1␣ by qPCR of iBAT (n ⫽ 6/group), H, miRNA expression of miR-30b, miR-193b, miR-196a, miR-365, and miR-378 (n ⫽ 6/group). All data
are presented as mean ⫾ S.E. A and G, values not sharing a common letter differ significantly (p ⬍ 0.05) by one-way ANOVA. H, *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍
0.001 by one-way ANOVA with comparison to LF control (n ⫽ 6 –7 per treatment).

els and by subsequent activation of functional miRNA network
for brown-specific gene transcription.

Discussion
Dietary FA are not only major nutrients but also key signaling
molecules that regulate endocrine function, immunological
responses, and energy metabolism (4). Emerging evidence suggests that dietary n-3 PUFA also trigger brown/beige fat activation (5, 7). It has been demonstrated that miRNAs play a crucial
role in regulating brown adipogenic program (28 –30). However, it has not been investigated whether n-3 PUFA participate
in regulating miRNA for brown/beige fat activation. The objecSEPTEBMER 23, 2016 • VOLUME 291 • NUMBER 39

tive of this work was to determine the impacts of n-3 PUFA on
classical brown adipogenesis by examining the miRNA network. Here, we demonstrated that the increase of brown adipogenesis by EPA was associated with the increase of several
miRNAs that are involved in functional cluster to stimulate
transcriptional activation of brown adipogenesis (Figs. 1 and 2).
The increase of these miRNAs was also confirmed in fish oil-fed
mice (Fig. 6). We have also demonstrated that activation of
Ffar4, n-3 PUFA receptor, is sufficient to simulate up-regulation of brown adipogenesis (Fig. 3), and these effects were abolished in the absence of Ffar4 expression (Fig. 4). By taking
advantage of mimics and LNA inhibitors, we identified that
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FIGURE 8. Working model that n-3 PUFA promotes brown adipogenesis
through FFAR4. n-3 PUFA such as EPA are sensed by membrane receptor
FFAR4 (A), which triggers a rise of intracellular cAMP levels (B) and biogenesis
of miRNAs, including miR-30b and miR-378 (C). Mature miRNA targets to their
complementary targets forming the miRNA (miR)-RISC complex (dotted box)
(D). For example, miR-30b attenuates its target gene expression of Rip140, a
nuclear receptor corepressor, thereby promoting transcriptional activity of
brown adipogenesis, including Prdm16, Ppar␥, Ppar␣, and Pgc1␣ (E). As a
consequence, n-3 PUFA up-regulate brown-specific transcriptional program,
including UCP1 and CIDEA as well as FFAR4 (F). In summary, Ffar4 plays a
significant role in mediating dietary n-3 PUFA-induced brown adipogenesis
partly through miR-30b; and miR-378-dependent mechanisms.

FIGURE 7. FFAR4 agonism elevates intracellular cAMP levels. A and B,
qPCR analysis of gene expression levels of Ucp1 and Ffar4 and miRNA 30b and
378 of iBAT before and after cold exposure (8 °C) for 2 weeks (A) or cold exposure with or without FO supplementation (B). C, cAMP levels in iBAT after
supplementation with LF or an iso-caloric HF diet containing 15% of palm oil
(HF ⫹ PO), olive oil (HF ⫹ OO), and fish oil (HF ⫹ FO), for 12 weeks (n ⫽ 6). D,
cAMP levels in brown adipocytes grown in the presence (⫹) and absence (⫺)
of 20 M GW9508 (n ⫽ 4). C, *, p ⬍ 0.05; ***, p ⬍ 0.001 by one-way ANOVA with
comparison to LF control (n ⫽ 6 per treatment). A, B, and D, *, p ⬍ 0.05; **, p ⬍
0.01; ***, p ⬍ 0.0001 by Student’s t test.

elevation of miR-30b was dependent on Ffar4 signaling, and
associated with EPA-mediated brown adipogenesis (Figs. 4 and
5). Our results also suggest that intracellular cAMP would be a
potential link between Ffar4 activation and brown-specific
miRNA modulation (Fig. 7). Based on these results, we propose
a model in which Ffar4 activation by dietary n-3 PUFA provides
an additional layer of transcriptional activation for brown adipogenesis in part through miR-30b and 378 (Fig. 8). To our
knowledge, our work is the first study reporting that Ffar4 functions to mediate n-3 PUFA-promoted brown adipogenic program via modulation of miRNAs.
miRNAs are single-stranded noncoding RNA composed of
19 –22 nucleotides. An individual miRNA can modulate hundreds of genes by regulating mRNA availability or translational
activity depending on the degree of complementarity with its
targets (31–33). No more than two dozen miRNAs have been
identified so far to up-regulate or down-regulate brown adipogenesis (34). As there was a tendency to increase the overall
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miRNA formation by EPA (Fig. 2C), we first speculated whether
EPA facilitated miRNA biogenesis or RNA-induced silencing
complex (RISC) formation. However, there was no difference in
Drosha, Dicer, and Ago2 expression (data not shown), and thus
we excluded the possibility that EPA alters early steps for
miRNA biogenesis or RISC formation. There is increasing literature support that the benefits of n-3 PUFA consumption are
mediated by miRNA regulation; Recchiuti et al. (35) demonstrated that the anti-inflammatory role of resolvin, n-3 PUFAderived eicosanoids, is associated with specific miRNA target
genes involved in resolution of acute inflammation (e.g. miR-21,
miR-146b, miR-208a, miR-203, miR-142, miR-302d, and miR219); Antal et al. (36) showed that miR-146 and miR-181a are
induced by docosahexaenoic acid in glioma cells increasing
sensitivity of radiation therapy. More recently, Ortega et al. (37)
suggested that dietary PUFA consumption is linked with
changes in plasma circulatory miRNA profiles. Given the broad
spectrum of health benefits by n-3 PUFA consumption from
cognitive function, cancer, inflammation, and dyslipidemia to
insulin sensitivity, miRNA regulation could provide a plausible
explanation on how n-3 PUFA alter hundreds of genes. In our
study, we have demonstrated that EPA or fish oil treatments
were associated with an increase of positive regulatory miRNA
for browning as a functional cluster (miR-196a, miR-193b/365,
miR-378, and miR-30b), but no significant changes were found
in a group of miRNAs negatively regulating brown adipogenesis
(miR-133, miR-27a, miR-106b/93, and miR-155) (Figs. 2C and
VOLUME 291 • NUMBER 39 • SEPTEBMER 23, 2016
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6H). It is also important that FFAR4 agonism by GW9508 has
mirrored the miRNA expression patterns in brown adipocytes
(Fig. 3B), strongly suggesting that Ffar4 signaling may directly
regulate miRNA synthesis in brown adipocytes. As far as we are
concerned, it is the first report to demonstrate that n-3 PUFAinduced BAT activation is linked with up-regulation of miRNA
in an Ffar4-dependent mechanism.
Among the set of miRNAs elevated by EPA treatment, we
have focused on miR-30b and miR378. As we used the primary
brown precursor cells (brown preadipocytes) isolated from
iBAT, we ruled out the possibility that miRNAs regulating lineage switch or brown commitment could play a major role, i.e.
miR-193b/365 (myoblast 3 brown precursor) (10) and miR196a (white 3 brown precursor) (11). Between the two
miRNAs tested, miR-30b and miR-378, miR-30b was our first
candidate for further investigation. This selection was based
upon the results that Rip140, the proposed target of miR-30b in
brown adipocytes, was decreased in response to an increase of
miR-30b in both EPA- and GW9508-treated brown adipocytes
(Figs. 2C and 3B), whereas the Pde1b expression level, miR-378
proposed target, was inconsistent with increased miR-387
expression. In addition, the decreased expression of Rip140
could induce a broad spectrum of changes in brown-specific
genes (38) by liberating restrictions on the nuclear receptors of
Ppar␥, Ppar␣, C/ebp␤, and Prdm16 (39, 40). Moreover, Rip140
plays an important role in anti-inflammation (41), which is well
aligned with the immunomodulatory role of n-3 PUFA. However, we cannot completely exclude the possibility that miR378 may contribute to EPA-mediated BAT activation. Based on
study by Kim et al. (7), fish oil supplementation is linked with
sympathetic activation and Adrb3 signaling in brown and
inguinal white adipocytes. This implies the activation of cAMP
production and its potential role of miR-378, specifically in
brown fat (12). To support this notion, sequestration of miR378 by the LNA inhibitor triggered a partial reduction of Ucp1
expression (Fig. 5). It is worth noting that the silencing of Ffar4
abolished the EPA-induced increase in miRNA expression of
both miR-30b and miR-378 (Fig. 4C). Intriguingly, the exogenous miR-30b mimic failed to rescue UCP1 up-regulation in
Ffar-silenced cells (Fig. 4D). These data implicate that Ffar4
signaling event must precede the production of miRNA functional cluster for up-regulation of brown thermogenesis. Based
on our current results, it is also speculated that once miRNAs
are formed via Ffar4 signaling, individual miRNAs may exert
separate impacts on their target genes, leading to augmented
brown adipogenesis as the sum of collaborative activities of
each miRNA. In addition, considering that FFAR4 agonism
induces cAMP responses (Fig. 7, C and D) and miRNA inhibitors only partly inhibit the Ffar4-mediated Ucp1 expression, we
do not exclude the possibility that FFAR4 agonism also promotes UCP1 transcription by microRNA-independent but
cAMP-dependent mechanisms.
In terms of signaling mediator, we propose that cAMP seems
to be the second messenger coordinating Ffar4 to transcriptional regulation of brown fat (Fig. 8). It is based on our following observations: 1) cold treatment triggers Ffar4 in iBAT (Fig.
7A), which was consistent with the studies by Rosell et al. (42);
2) FO supplementation showed an additional up-regulation
SEPTEBMER 23, 2016 • VOLUME 291 • NUMBER 39

Ffar4; and 3) Ffar4 agonism is associated with a rise of cAMP
levels in brown adipocyte in vitro as well as in iBAT in vivo (Fig.
7, C and D). These data strongly suggest the positive association
between Ffar4 activation and cAMP levels. Considering that
Ffar4 (Gpr120) is a family of G protein-coupled receptors with
G␣q subunits, the primary signaling mediator is intracellular
calcium ([Ca2⫹]i) (43). Although it could be controversial,
Moran et al. (44) demonstrated that augmented insulin secretion by FFAR4 agonism in pancreatic ␤-cell is accompanied by
significant elevation of cAMP as well as [Ca2⫹]i. Our results
showed that cAMP levels were significantly higher in fish oilfed iBAT (Fig. 7). It could be due to an activation of sympathetic
nervous system and Adrb3 pathway by n-3 PUFA, as proposed
by Kim et al. (7). Therefore, it was surprising when we were able
to determine the rise of cAMP levels in EPA-treated brown
adipocytes, an isolated brown adipocyte system. Although we
could not completely exclude the possibility that Ffar4 signaling may be involved in catecholamine production within brown
adipocytes (45), we speculate that either Ffar4 signaling contributes to a delay of cAMP degradation or a rise of cAMP via
miRNA-mediated mechanism. We are currently investigating
whether Ffar4 agonism is linked with PKA activation or [Ca2⫹]i
signaling for cAMP regulation.
It is well accepted that the n-6/n-3 ratio is a biomarker used
for prediction of chronic disease risk, including cardiovascular
diseases and diabetes. Our animal experiment showed that fish
oil supplementation decreased the n-6/n-3 ratio by ⬃5-fold
compared with palm oil or olive oil supplementation. However,
our in vitro experiment revealed that Ffar4 signaling activity is
necessary and sufficient to simulate EPA-mediated brown thermogenesis (Figs. 3 and 4). It is uncertain whether Ffar4 signaling is more crucial than n-6/n-3 ratio itself. Interestingly, Li et
al. showed that the anti-inflammatory function of n-3 PUFA is
dependent on Ffar4 signaling. They used transgenic fat-1 mice,
an engineered mice to endogenously synthesize n-3 PUFA from
n-6 PUFA by overexpressing n-3 desaturase fat-1, thereby the
n-6/n-3 ratio remains low (46). When FFAR4 is deleted in Fat-1
mice (FFAR4⫺/⫺/fat-1), the n-3 PUFA-mediated anti-inflammation effects in the vasculature disappeared despite the similar levels in the n-6/n-3 ratio (47). These results suggest that
Ffar4 signaling activity, rather than cellular loading of n-3
PUFA, may mediate health benefits. Consistent with this concept, treatment of selective Ffar4 agonist effectively reproduced
n-3 PUFA-mediated anti-inflammatory and insulin-sensitizing
effects without n-3 PUFA consumption. Until now, little information is available regarding the browning of Ffar4 knock-out
animals, although it has been demonstrated that Ffar4 deletion
precipitates obesity and insulin resistance (21). We are currently investigating whether Fat-1 mice alter the miRNA network that we observed in Fig. 2 without any supplementation or
FFAR4 agonist treatment.
In this study, we mainly focused on investigating the effects
of EPA on brown adipogenesis using brown progenitor cells,
but we did not specifically address the role of EPA on the beigeing of white adipocytes. It has been suggested that EPA (or fish
oil) could trigger brown-like phenotypes in adipocyte progenitor cells isolated from rodent subcutaneous fat in vitro (5) and
primary human adipose-derived stem cells (48). These results
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are inconsistent with our preliminary study that GW9508 treatment in human adipose-derived stem cells increased the adipogenesis but decreased UCP1 expression without any significant
changes in oxygen consumption rate (data not shown). In addition, GW9508 treatment decreased the bone morphogenetic
protein 7 (BMP7)-mediated UCP1 expression in primary
human white adipocytes (data not shown). Further studies are
warranted to reconcile this controversy by measuring metabolic activities in the presence or absence of ADRB3 stimulation rather than UCP1 gene expression. There is a study
showing that depletion of Ffar4 impairs white adipocyte differentiation (49). Therefore, it is plausible that white adipose tissue browning by n-3 PUFA might be a separate mechanism
from augmented brown adipogenesis of classical brown fat. As
white adipose tissue browning (or beige fat formation) is more
critically regulated by the immunological status of WAT (50),
we envision that the decrease of lipotoxicity and modulation of
immune responses in white adipose tissue (e.g. macrophage M2
polarization) by n-3 PUFA facilitate white adipocyte browning,
whereas FFAR4 signaling accompanying the miRNA network
activates classical brown fat development upon n-3 PUFA
supplementation.
In summary, here we report that the activation of FFAR4, a
functional receptor for sensing n-3 PUFA, potentiates transcriptional activation of brown adipogenesis through modulation of miRNAs, including miR-30b and miR-378. We also propose that elevation of cAMP is a likely downstream pathway
coordinating Ffar4 signaling to the transcriptional activation of
brown adipogenic program. Although further investigations
are necessary to validate these results in human classical brown
adipocytes or pluripotent stem cells, our study provides novel
insights into the development of dietary intervention strategies
to increase BAT development. In contrast to the temporal and
reversible Ucp1 activation of beige fat, classical brown fat constitutively activates thermogenesis through Ucp1. Given this
clinical relevance of BAT to energy metabolism, this study will
provide evidence for therapeutic application to boost BAT via
activation of Ffar4/miRNA signaling axis.

Experimental Procedures
Chemicals—Fetal bovine serum (FBS) was purchased from
Gibco. Rosiglitazone (BRL) was purchased from Cayman
Chemical. Insulin, 3-isobutyl-1-methylxanthine, and trifluoride (BF3)/methanol reagent were purchased from Sigma. Palmitic acid, oleic acid, EPA, and fatty acid standard were purchased from NuChek Prep (Elysian, MN). GW9508, an FFAR4
agonist, was purchased from Tocris Bioscience (Bristol, UK).
Animals—All protocols and procedures were approved by
the Institutional Animal Care and Use Committee at the University of Nebraska, Lincoln. C57BL/6 male mice were purchased at 6 weeks of age from The Jackson Laboratory. After 2
weeks of acclimation, the mice were randomly assigned into
four diet groups (n ⫽ 8 per group) receiving either a low fat (LF;
10% calories from fat) diet or an iso-caloric high fat (HF; 50%
calories from fat) diet that was enriched with different FA for 12
weeks. The AIN-93G rodent formulation was modified for fat
composition containing 15% of fat (w/w) from either palm oil
(HF ⫹ PO), olive oil (HF ⫹ OO), or fish oil (HF ⫹ FO). All diets
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contained the same amount of soy bean oil (5% w/w) as a source
for essential FA. Gas chromatography (GC) was used to analyze
the fatty acid profile as described under “n-6/n-3 Ratio.” At the
time of necropsy, blood, subcutaneous (inguinal) WAT, and
iBAT were collected, snap-frozen in liquid nitrogen, and kept at
⫺80 °C until analysis.
Brown Progenitor Cell Isolation and Differentiation—The
6 –7-week-old C57BL/6 mice were purchased from The Jackson Laboratory. iBAT were used for brown progenitor cell isolation. Excised iBAT were immediately washed in PBS, minced
into small pieces (1–2 mm), and digested with collagenase (1
mg/ml) in a Krebs-Ringer bicarbonate buffer in a shaking water
bath (37 °C). After 1 h of digestion, stromal vascular cells were
collected by centrifugation, and the resulting pellet was filtered
through a 100-m cell strainer. After centrifugation, the
obtained stromal vascular fraction was seeded into a 12-well
plate and cultured in a complete medium (DMEM plus 10%
FBS) until confluence. Adipocyte differentiation was induced
by adding the differentiation mixture, which contained 20 nM
insulin, 1 nM triiodothyronine, 0.5 mM isobutylmethylxanthine,
5 M dexamethasone, 0.125 mM indomethacin, and 0.5 M
rosiglitazone brl 49653 for 2 days. Then, a fresh medium containing 20 nM insulin and 1 nM triiodothyronine were added to
cells along with either 100 M BSA-complexed FA, i.e. PA, OA,
EPA, or 20 M GW9508 for additional 5 days.
Rectal Temperature and Thermogenesis—To measure the
core body temperature, a digital thermometer (TC Thermocouple Meter) was used in combination with a copper thermocouple rectal probe (RET-3) (Kent Scientific Corp). The probe
was properly positioned into the anal ducts of the adult mice to
record temperature. An average of three readings obtained
from the same mouse was calculated. For the detection of thermal release, an infrared (IR) camera (A655sc, FLIR Systems)
was used to acquire images of the body surface temperature of
each mouse. The images were displayed using the rainbow high
contrast color palette in the FLIR Research IR program using a
temperature linear display between 25 and 34 °C.
DEXA—Body composition for the mice was measured by
using a dual energy x-ray absorptiometry (DEXA). The mice
were anesthetized with CO2 and scanned using a Lunar PIXImus2 densitometer (software version 2.1; Lunar Corp). All of
the mice were weighed before the DEXA measurements.
Immediately after the DEXA analysis, blood was collected, and
the mice were killed by cervical dislocation.
n-6/n-3 Ratio—The fatty acid profiles of the fat samples were
determined by GC (51). Briefly, ⬃0.1g of tissue was homogenized, and total lipids were extracted. They were then subjected
to fatty acid methylation by 14% BF3/methanol reagent at
100 °C for 1 h. An Agilent Technologies HP-88 column (100
m ⫻ 0.25 mm ⫻ 0.2 m film thickness) was used. The fatty acid
peaks were identified by comparing their relative retention
times with the commercial mixed FA standard (NuChek PreP),
and the area percentages for all resolved peaks were analyzed
using the GC ChemStation software.
OCR by Seahorse—To determine the mitochondrial respiration activities, the O2 concentration in the cells was measured
using XF24 extracellular flux analyzer (Seahorse). Briefly,
mouse brown primary cells were seeded in gelatin-coated seaVOLUME 291 • NUMBER 39 • SEPTEBMER 23, 2016

FFAR4 and Brown Thermogenesis
horse microplates (24-well) until confluence was reached followed by brown differentiation as we described above. The
mitochondrial basal respiration was assessed in untreated cells.
The cells were then treated with oligomycin (1 M) to measure
the ATP turnover. The maximum respiratory capacity was
assessed by addition of carbonyl cyanide 4-trifluoromethoxy
phenylhydrazone (FCCP, 0.3 M), a chemical uncoupler of electron transport and oxidative phosphorylation. The mitochondrial respiration was blocked by antimycin A (1 M) plus rotenone (1 M). The OCR was calculated by plotting the O2
tension of the medium in the microenvironment above the cells
as a function of time (pmol of O2/min).
qPCR of mRNA and microRNA—Total RNA was extracted
using TRIzol威 reagent (Invitrogen) from homogenized tissues
or cells. RNA was purified using DNase (5 PRIME). One g of
RNA was converted into cDNA (iScript, Bio-Rad). Relative
gene expression was determined based on the 2⫺⌬⌬CT method
with normalization of the raw data to 36b4 (primer sequences
are available upon request). For miRNA analysis, miRNA was
converted to cDNA using the miScript reverse transcription kit
(Qiagen) according to the manufacturer’s instructions. miRNA
expression was measured by using the commercial miScript
Universal Primer, with the miScript primer assay kit (Qiagen).
Primers of miR-16, -27a, -30b, -93, -106b, -133a, -155, -193b,
-196, -365, and -378 and RNU6-2 were purchased from Qiagen.
Values were normalized to RNU6-2 (U6 small nuclear) and also
confirmed with miR-16.
Transfection of miRNA Mimic, Inhibitors, and Silencing
FFAR4 —For transfection of miR-30b mimic, brown precursor
cells were first seeded in a 12-well plate at 60 –70% confluence.
The next day, transfection was performed for 2 days with 10 nM
miRCURY locked nucleic acid (LNATM) miR-30b mimic (miR30b mimic, Exiqon471216-001) or non-targeting negative control (Exiqon479902-001). To deplete FFAR4 expression, 100 nM
ON TARGET plus SMARTpool siRNAs (Mouse FFAR4) or
Non-Targeting siRNA Pool (Dharmacon) were transfected into
cells using DharmaFECT-1 (GE Dharmacon) according to the
manufacturer’s instructions. After 48 h of post-transfection,
adipocyte differentiation was initiated by adding the differentiation mixture as we described previously. miRCURY LNA
Power inhibitors of miR-30b (4102487-101, Exiqon), miR-378
(4100837-101, Exiqon), or respective negative control (199006001, Exiqon) were transfected according to the manufacturer’s
instructions. The final oligonucleotide concentrations were 10
nM for LNA miR-30b inhibitor and 100 nM for LNA miR-378a
inhibitor. After 48 h of post-transfection, the cells were induced
to differentiation.
Western Blotting Analysis—Total cell extracts were prepared
as described previously (27). Proteins were fractionated using
4 –15% precast polyacrylamide gel (Bio-Rad) and transferred to
PVDF membranes with a semi-dry transfer unit (Hoefer
TE77X). Antibody targeting UCP1 (14670), PPAR␥ (2444), and
␤-actin (4967) was purchased from Cell Signaling Technology.
aP2 (sc-271529) and PRDM16 (sc-55697) were purchased
from Santa Cruz Biotechnology. Blots were visualized with
FluorChemTME imaging system (Protein Simple).
cAMP Analysis—To measure cAMP levels, immunoassay
was conducted by using mouse/rat cAMP parameter assay kit
SEPTEBMER 23, 2016 • VOLUME 291 • NUMBER 39

(R&D System) according to the manufacturer’s protocol. cAMP
levels were normalized with either total protein or milligram of
tissue used.
Statistical Analysis—All data are presented as means of ⫾
S.E. Independent samples were statistically analyzed using oneway ANOVA followed by Tukey’s multiple comparison tests for
comparisons between two groups or comparison to the control.
All statistical analyses were conducted by Graph Pad Prism 6
(Version 6.02).
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